BIOMAT Database Logo BIOMAT Database Logo

Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. 1992

F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Center for Medical Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Norrie disease is a rare X-linked recessive disorder characterized by blindness from infancy. The gene for Norrie disease has been localized to Xp11.3. More recently, the genes for monoamine oxidase (MAOA, MAOB) have been mapped to the same region. This study evaluates the clinical, biochemical, and neuropsychiatric data in an affected male and 2 obligate heterozygote females from a single family with a submicroscopic deletion involving Norrie disease and MAO genes. The propositus was a profoundly retarded, blind male; he also had neurologic abnormalities including myoclonus and stereotopy-habit disorder. Both obligate carrier females had a normal IQ. The propositus' mother met diagnostic criteria for "chronic hypomania and schizotypal features." The propositus' MAO activity was undetectable and the female heterozygotes had reduced levels comparable to patients receiving MAO inhibiting antidepressants. MAO substrate and metabolite abnormalities were found in the propositus' plasma and CSF. This study indicates that subtle biochemical and possibly neuropsychiatric abnormalities may be detected in some heterozygotes with the microdeletion in Xp11.3 due to loss of the gene product for the MAO genes; this deletion can also explain some of the complex phenotype of this contiguous gene syndrome in the propositus.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D009207 Myoclonus Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3). Myoclonus, Action,Myoclonus, Nocturnal,Myoclonus, Palatal,Polymyoclonus,Myoclonic Jerk,Myoclonic Jerking,Myoclonus Simplex,Myoclonus, Eyelid,Myoclonus, Intention,Myoclonus, Lower Extremity,Myoclonus, Oculopalatal,Myoclonus, Segmental,Myoclonus, Sleep,Myoclonus, Upper Extremity,Action Myoclonus,Extremity Myoclonus, Lower,Extremity Myoclonus, Upper,Eyelid Myoclonus,Intention Myoclonus,Jerk, Myoclonic,Jerking, Myoclonic,Jerks, Myoclonic,Lower Extremity Myoclonus,Myoclonic Jerks,Nocturnal Myoclonus,Oculopalatal Myoclonus,Palatal Myoclonus,Segmental Myoclonus,Simplex, Myoclonus,Sleep Myoclonus,Upper Extremity Myoclonus
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001766 Blindness The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE. Amaurosis,Bilateral Blindness,Blindness, Bilateral,Blindness, Legal,Blindness, Monocular,Blindness, Unilateral,Sudden Visual Loss,Unilateral Blindness,Blindness, Acquired,Blindness, Complete,Blindness, Hysterical,Blindness, Transient,Acquired Blindness,Amauroses,Bilateral Blindnesses,Complete Blindness,Hysterical Blindness,Legal Blindness,Monocular Blindness,Sudden Visual Losses,Transient Blindness,Visual Loss, Sudden
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy.
May 2007, American journal of medical genetics. Part A,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Xp11.3 microdeletion causing Norrie disease and X-linked Kabuki syndrome.
March 2023, American journal of ophthalmology case reports,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Analysis of the monoamine oxidase genes and the Norrie disease gene locus in narcolepsy.
February 1999, Lancet (London, England),
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Norrie disease gene is distinct from the monoamine oxidase genes.
September 1989, American journal of human genetics,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
maoB, a gene that encodes a positive regulator of the monoamine oxidase gene (maoA) in Escherichia coli.
May 1996, Journal of bacteriology,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
A novel contiguous deletion involving NDP, MAOB and EFHC2 gene in a patient with familial Norrie disease: bilateral blindness and leucocoria without other deficits.
December 2017, Journal of genetics,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease.
May 1989, Genomics,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
A ScaI polymorphism at the ovine monoamine oxidase A locus (MAOA).
December 1997, Animal genetics,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
March 1999, Movement disorders : official journal of the Movement Disorder Society,
F A Collins, and D L Murphy, and A L Reiss, and K B Sims, and J G Lewis, and L Freund, and F Karoum, and D Zhu, and I H Maumenee, and S E Antonarakis
The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3.
May 1992, Human molecular genetics,
Copied contents to your clipboard!